We help you navigate the challenges of the industry and drive your growth agenda.
The cannabis industry is blossoming. With the upcoming legalization of cannabis for recreational use by the Federal Government, the sector is expected to grow as producers, manufacturers, and companies from across the value chain embrace opportunities in both the recreational and medical markets.
Where there is opportunity there is also uncertainty. Disruption in the sector is a question of when, not if, as existing companies grow, large adjacent players may enter and the regulatory environment continues to evolve. If you are a cannabis company, an investor or potential investor, you know there are considerable issues and challenges rapidly approaching.
Our dedicated cannabis specialists can help you navigate the road ahead. We will help you identify and secure the right strategies, capabilities, partnerships and tools for success.
Darren Henderson
Partner
Tel: +1 416 941 8379
Email
The LCBO has gone from being a standalone retailer to playing a number of roles including wholesaler, ecommerce provider and soon to be cannabis retailer. In this episode of Shift, LCBO’s President & CEO, George Soleas, joins Jon Finkelstein to discuss the crown corporation’s digital transformation, customer centricity, AI and of course, cannabis retail, including its implications for alcohol.
Welcome to PwC's series of points of view on the cannabis industry in Canada. The aim of this series is to explore how companies can prepare to thrive in this complex new world while covering a range of topics and issues from strategy, to core capabilities, technology, M&A, restructuring and bankruptcy as well as tax and audit preparedness for expansion.
These points of view leverage the knowledge of our dedicated team of cannabis industry specialists, who have identified a number of imminent changes to the industry that will fundamentally alter the market landscape and affect all current and future players.
The points of view are provided for educational purposes and for general understanding of the cannabis landscape, not to provide specific financial, investment or other advice. These publications should not be used as a substitute for competent financial, investment or other advice from a professional services firm.
For years, registered patients in Canada have had legal access to medicinal cannabis, and if the federal government's plan remains on track for this summer, Canada will become the first G-7 country to legalize adult-use cannabis.
A maturing market brings new realities and signs point to some investor fatigue. Cannabis companies will need to differentiate to win in a crowded market. What's your strategy?
With a market offering plenty of opportunities, cannabis companies will need to understand the difference between critical capabilities and enablers to be able to deliver on their strategy.
Entrepreneurs in the cannabis industry are moving at warp speed to get their businesses up and running in time for the Canadian government’s legalization of adult-use cannabis, creating billions of dollars of value in the process. Most companies however, have failed to implement appropriate technology strategies during this boom, putting much of that equity at risk.
With the current fragmentation in the industry, cannabis companies flush with cash are on a buying spree. Large transformational deals are likely to continue during this phase of the cannabis boom.
The revolutionary legislation for the legalization of recreational cannabis is set to be enacted in 2018, compelling Canadian institutions to reshape how they operate legally, socially and economically. To bring this legislation to market in a responsible way, many regulatory and operational changes must be made.
Darren Henderson
Partner, PwC Canada
Tel: +1 416 941 8379
Email
Rami El-Cheikh
National Pharma & Life Sciences Leader, PwC Canada
Tel: +1 647 669 4555
Email
